Atrium goes to Germany
This article was originally published in The Tan Sheet
Executive Summary
Atrium Innovations will expand its operations into Germany with the $175 mil. acquisition of German OTC and dietary supplements maker Mucos Emulsions, Atrium announces July 12. The acquisition gives Atrium a "privileged access to the German market, the largest European market for dietary supplements," and allows the firm to establish its European Health and Nutrition Division, the company says. Mucos' top brand is Wobenzym, "Germany's most popular natural anti-inflammatory product," and Atrium expects the buy to increase its earnings by approximately $27 mil., the firm says. The deal "should be followed by further acquisitions and strong organic growth as we did in the United States and Canada," Atrium CEO Pierre Fitzgibbon says...